These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1923330)

  • 21. Allergic conjunctivitis: an update on diagnosis and management.
    O'Brien TP
    Curr Opin Allergy Clin Immunol; 2013 Oct; 13(5):543-9. PubMed ID: 23974684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of disodium cromoglycate in vernal conjunctivitis.
    Vajpayee R; Kumar S; Sharma M
    Indian J Ophthalmol; 1985; 33(3):151-3. PubMed ID: 3939423
    [No Abstract]   [Full Text] [Related]  

  • 23. Vernal keratoconjunctivitis in an Israeli group of patients and its treatment with sodium cromoglycate.
    Baryishak YR; Zavaro A; Monselise M; Samra Z; Sompolinsky D
    Br J Ophthalmol; 1982 Feb; 66(2):118-22. PubMed ID: 6800400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyposensitization in the treatment of resistant cases of vernal keratoconjunctivitis.
    Mahdy RA; Nada WM; Shahien EA; Boghdadi GA; Marei AA
    Cutan Ocul Toxicol; 2010 Sep; 29(3):198-202. PubMed ID: 20670088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of retinal nerve fiber layer thickness in vernal keratoconjunctivitis patients under long-term topical corticosteroid therapy.
    Cingu AK; Cinar Y; Turkcu FM; Sahinoglu-Keskek N; Sahin A; Sahin M; Yuksel H; Caca I
    Cutan Ocul Toxicol; 2014 Sep; 33(3):184-8. PubMed ID: 24021018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of vernal keratoconjunctivitis with topical cromolyn sodium.
    Chin GN
    J Pediatr Ophthalmol Strabismus; 1978; 15(5):326-9. PubMed ID: 24877437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM; Avunduk MC; Kapicioglu Z; Akyol N; Tavli L
    Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis].
    Doan S; Gabison E; Abitbol O; Gatinel D; Chast F; Hoang-Xuan T
    J Fr Ophtalmol; 2007 Sep; 30(7):697-701. PubMed ID: 17878822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tailored approach to the treatment of vernal keratoconjunctivitis.
    Sacchetti M; Lambiase A; Mantelli F; Deligianni V; Leonardi A; Bonini S
    Ophthalmology; 2010 Jul; 117(7):1294-9. PubMed ID: 20382430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lodoxamide in vernal keratoconjunctivitis.
    Lee S; Allard TR
    Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vernal keratoconjunctivitis].
    Heinz C; Heiligenhaus A
    Klin Monbl Augenheilkd; 2014 May; 231(5):505-11. PubMed ID: 24799169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
    Yücel OE; Ulus ND
    Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating severe eye allergy.
    Verin P
    Clin Exp Allergy; 1998 Dec; 28 Suppl 6():44-8. PubMed ID: 9988435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Allergic conjunctivitis in children].
    Zepeda Ortega B; Rosas Vargas MA; Ito Tsuchiya FM; del Río Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2007; 54(2):41-53. PubMed ID: 17542245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of medical treatments for vernal keratoconjunctivitis: A systematic review and meta-analysis.
    Roumeau I; Coutu A; Navel V; Pereira B; Baker JS; Chiambaretta F; Bremond-Gignac D; Dutheil F
    J Allergy Clin Immunol; 2021 Sep; 148(3):822-834. PubMed ID: 33819510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis.
    Senthil S; Thakur M; Rao HL; Mohamed A; Jonnadula GB; Sangwan V; Garudadri CS
    Br J Ophthalmol; 2020 Feb; 104(2):265-269. PubMed ID: 31055451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical evaluation of sodium cromproxate in vernal keratoconjunctivitis].
    Pan YQ
    Zhonghua Yan Ke Za Zhi; 1987 May; 23(3):168-71. PubMed ID: 3113892
    [No Abstract]   [Full Text] [Related]  

  • 39. Vernal Keratoconjunctivitis in Kashmir: A temperate zone.
    Sofi RA; Mufti A
    Int Ophthalmol; 2016 Dec; 36(6):875-879. PubMed ID: 26961753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vernal Keratoconjunctivitis as the Only Clinical Manifestation of HIV Infection.
    Farias RJM; Gama MEA; Mendes R; Lobão NTM; Barbosa de Sousa L
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1530-1532. PubMed ID: 33826485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.